Weaver Consulting Group Edwards Lifesciences Corp Transaction History

Weaver Consulting Group

$293 Million
Q1 2025

A detailed history of Weaver Consulting Group transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Weaver Consulting Group holds 46,585 shares of EW stock, worth $3.62 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

46,585

Previous 46,935 0.75%

Holding current value

$3.62 Million

Previous $3.47 Million 2.82%

% of portfolio

1.15%

Previous 1.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	SELL	$67.95 - $76.19 $23,782 - $26,666	-350 Reduced 0.75%	46,585 $3.38 Million
Q4 2024 Jan 07, 2025	SELL	$64.54 - $75.92 $36,013 - $42,363	-558 Reduced 1.17%	46,935 $3.47 Million
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $21,432 - $33,667	-359 Reduced 0.75%	47,493 $3.13 Million
Q2 2024 Jul 12, 2024	BUY	$84.3 - $94.31 $708,120 - $792,204	8,400 Added 21.29%	47,852 $4.42 Million
Q1 2024 Apr 16, 2024	SELL	$72.54 - $95.56 $72,540 - $95,560	-1,000 Reduced 2.47%	39,452 $3.77 Million
Q4 2023 Jan 22, 2024	SELL	$61.71 - $77.76 $134,836 - $169,905	-2,185 Reduced 5.12%	40,452 $3.08 Million
Q3 2023 Oct 13, 2023	BUY	$69.28 - $93.38 $105,582 - $142,311	1,524 Added 3.71%	42,637 $2.95 Million
Q2 2023 Jul 19, 2023	SELL	$81.41 - $94.33 $162 - $188	-2 Reduced -0.0%	41,113 $3.88 Million
Q1 2023 Apr 11, 2023	SELL	$74.26 - $84.51 $74 - $84	-1 Reduced -0.0%	41,115 $3.4 Million
Q4 2022 Jan 09, 2023	BUY	$68.3 - $87.44 $106,957 - $136,931	1,566 Added 3.96%	41,116 $0
Q3 2022 Oct 04, 2022	BUY	$82.37 - $107.29 $6,260 - $8,154	76 Added 0.19%	39,550 $3.27 Million
Q2 2022 Jul 20, 2022	BUY	$86.5 - $128.27 $47,488 - $70,420	549 Added 1.41%	39,474 $3.75 Million
Q1 2022 May 06, 2022	BUY	$101.96 - $128.34 $20,392 - $25,668	200 Added 0.52%	38,925 $4.58 Million
Q4 2021 Feb 01, 2022	BUY	$106.37 - $130.68 $319 - $392	3 Added 0.01%	38,725 $5.02 Million
Q3 2021 Oct 28, 2021	BUY	$102.91 - $122.75 $12,143 - $14,484	118 Added 0.31%	38,722 $4.38 Million
Q2 2021 Jul 06, 2021	BUY	$83.84 - $104.76 $65,395 - $81,712	780 Added 2.06%	38,604 $4 Million
Q1 2021 Apr 07, 2021	BUY	$78.68 - $90.67 $117,547 - $135,460	1,494 Added 4.11%	37,824 $3.16 Million
Q4 2020 Jan 29, 2021	BUY	$71.69 - $91.23 $48,390 - $61,580	675 Added 1.89%	36,330 $3.31 Million
Q3 2020 Oct 28, 2020	BUY	$67.19 - $87.44 $105,824 - $137,718	1,575 Added 4.62%	35,655 $2.85 Million
Q2 2020 Jul 24, 2020	BUY	$57.54 - $76.95 $1.29 Million - $1.73 Million	22,499 Added 194.28%	34,080 $2.36 Million
Q1 2020 Apr 28, 2020	BUY	$52.41 - $81.0 $11,163 - $17,253	213 Added 1.87%	11,581 $2.18 Million
Q4 2019 Jan 31, 2020	BUY	$71.7 - $82.09 $32,623 - $37,350	455 Added 4.17%	11,368 $2.5 Million
Q2 2019 Aug 05, 2019	SELL	$55.74 - $64.41 $7,246 - $8,373	-130 Reduced 1.18%	10,913 $2.02 Million
Q1 2019 Jun 19, 2019	BUY	$47.89 - $64.05 $528,849 - $707,304	11,043 New	11,043 $2.05 Million

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

486M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $48.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Account

Weaver Consulting Group Edwards Lifesciences Corp Transaction History